Sills; Matthew
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sills; Matthew.The latest application filed is for "low-latency database system".
- Sills; Matthew - New York NY
- Sills; Matthew - San Francisco CA
- Sills; Matthew - Berkeley Heights NJ
- - Berkeley Heights NJ US
| Patent | Date |
|---|---|
| Low-latency Database System App 20220058194 - Elliot; Mark ; et al. | 2022-02-24 |
| Projections For Big Database Systems App 20220058183 - Duffield; Benjamin ; et al. | 2022-02-24 |
| Approaches For Managing Data Retention Lifecycle App 20210240659 - Wee; Yeong Wei ; et al. | 2021-08-05 |
| Approaches for managing data retention lifecycle Grant 10,983,950 - Wee , et al. April 20, 2 | 2021-04-20 |
| Context Aware Hearing Optimization Engine App 20200380979 - Meacham; Jacob ; et al. | 2020-12-03 |
| Methods and systems for determining location information Grant 10,706,434 - Brainard , et al. | 2020-07-07 |
| Approaches For Managing Data Retention Lifecycle App 20190147064 - Wee; Yeong Wei ; et al. | 2019-05-16 |
| Methods And Systems For Analyzing Entity Performance App 20190020557 - Chang; Allen ; et al. | 2019-01-17 |
| Methods and systems for analyzing entity performance Grant 10,103,953 - Chang , et al. October 16, 2 | 2018-10-16 |
| Context Aware Hearing Optimization Engine App 20180247646 - Meacham; Jacob ; et al. | 2018-08-30 |
| Context aware hearing optimization engine Grant 9,886,954 - Meacham , et al. February 6, 2 | 2018-02-06 |
| Combination therapy with MDM2 and EFGR inhibitors Grant 9,273,031 - Errico , et al. March 1, 2 | 2016-03-01 |
| Methods of targeted drug development Grant 9,073,858 - Errico , et al. July 7, 2 | 2015-07-07 |
| Combination therapy with MDM2 and EFGR inhibitors Grant 9,023,354 - Errico , et al. May 5, 2 | 2015-05-05 |
| Combination Therapy With Mdm2 And Efgr Inhibitors App 20150105412 - Errico; Joseph P. ; et al. | 2015-04-16 |
| Methods Of Targeted Drug Development App 20140194439 - Errico; Joseph P. ; et al. | 2014-07-10 |
| Methods And Compositions Of Targeted Drug Development App 20140179681 - Errico; Joseph P. ; et al. | 2014-06-26 |
| Compositions Of Targeted Drug Development App 20140163069 - Errico; Joseph P. ; et al. | 2014-06-12 |
| Combination Therapy With Mdm2 And Efgr Inhibitors App 20140134163 - Errico; Joseph P. ; et al. | 2014-05-15 |
| Combination therapy with MDM2 and EFGR inhibitors Grant 8,658,170 - Errico , et al. February 25, 2 | 2014-02-25 |
| Methods and compositions of targeted drug development Grant 8,618,302 - Errico , et al. December 31, 2 | 2013-12-31 |
| Methods and compositions of targeted drug development Grant 08618302 - | 2013-12-31 |
| Combination Therapy With Mdm2 And Efgr Inhibitors App 20120156197 - Errico; Joseph P. ; et al. | 2012-06-21 |
| Methods And Compositions Of Targeted Drug Development App 20110301193 - Errico; Joseph P. ; et al. | 2011-12-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 